Meeting
2023 ASCO Gastrointestinal Cancers Symposium
A phase II study of preoperative chemotherapy with docetaxel, oxaliplatin, and S-1 followed by gastrectomy with D2 plus para-aortic nodal dissection for gastric cancer with extensive lymph node metastasis: JCOG1704.
Authors
Takaki Yoshikawa
Department of Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan;
Takaki Yoshikawa , Yukinori Kurokawa , Ryo Kitabayashi , Junki Mizusawa , Takashi Nomura , Kunihiro Tsuji , Ryo Tanaka , Haruhiko Cho , Jun Hihara , Naoki Hiki , Souya Nunobe , Narikazu Boku , Yuichiro Doki , Masanori Terashima
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
jRCTs031180028
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 354)
DOI
10.1200/JCO.2023.41.4_suppl.354
Abstract #
354
Poster Bd #
E15
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
A modified triplet combination of docetaxel, oxaliplatin, and fluorouracil for gastric cancer (GC) with peritoneal carcinomatosis (PC) and inoperable malignant bowel obstruction (MBO): A multi-center, non-randomized, three-cohort, phase II trial (Zhen Jing).
First Author: Jian Xiao
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Randomized phase II study comparing neoadjuvant FLOT versus DOS for patients with type 4 or large type 3 gastric cancer (JCOG2204).
First Author: Izuma Nakayama
Poster
2024 ASCO Gastrointestinal Cancers Symposium
A phase II trial of CapeOX plus nivolumab for early relapsed HER2-negative gastric cancer (JACCRO GC-11: FirSTAR trial).
First Author: Hiroyuki Arai
Poster
2020 Gastrointestinal Cancers Symposium
Feasibility and pathological response of TAS-118 + oxaliplatin as perioperative chemotherapy for patients with locally advanced gastric cancer (APOLLO-11).
First Author: Daisuke Takahari